These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36875557)

  • 1. Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury.
    Prowle JR; Artigas A; Bagshaw SM; Forni LG; Heung M; Hoste E; Marlies O; Koyner JL; Chawla L; Kampf JP; Kwan T; McPherson P; Kellum JA
    Crit Care Explor; 2023 Mar; 5(3):e0870. PubMed ID: 36875557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury.
    Koyner JL; Chawla LS; Bihorac A; Gunnerson KJ; Schroeder R; Demirjian S; Hodgson L; Frey JA; Wilber ST; Kampf JP; Kwan T; McPherson P; Kellum JA;
    Kidney360; 2022 Jul; 3(7):1158-1168. PubMed ID: 35919538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury.
    Bagshaw SM; Al-Khafaji A; Artigas A; Davison D; Haase M; Lissauer M; Zacharowski K; Chawla LS; Kwan T; Kampf JP; McPherson P; Kellum JA
    Crit Care; 2021 May; 25(1):185. PubMed ID: 34059102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study.
    Hoste E; Bihorac A; Al-Khafaji A; Ortega LM; Ostermann M; Haase M; Zacharowski K; Wunderink R; Heung M; Lissauer M; Self WH; Koyner JL; Honore PM; Prowle JR; Joannidis M; Forni LG; Kampf JP; McPherson P; Kellum JA; Chawla LS;
    Intensive Care Med; 2020 May; 46(5):943-953. PubMed ID: 32025755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early recovery status and outcomes after sepsis-associated acute kidney injury in critically ill patients.
    Luo X; Yan P; Zhang N; Wang M; Deng Y; Wu T; Wu X; Liu Q; Wang H; Wang L; Kang Y; Duan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):535-545. PubMed ID: 35753723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability performance of urinary C-C motif chemokine ligand 14 and renal resistive index for persistent sepsis-associated acute kidney injury in ICU patients.
    Jiang W; Liao T; Yu J; Shao J; Zheng R
    Int Urol Nephrol; 2023 Aug; 55(8):1995-2003. PubMed ID: 36797554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients.
    Matsa R; Ashley E; Sharma V; Walden AP; Keating L
    Crit Care; 2014 Jul; 18(4):R137. PubMed ID: 24985156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
    McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
    Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Urinary NGAL as a Diagnostic Tool for Acute Kidney Injury in Critically Ill Patients With Infection: An Original Study.
    Gomes BC; Silva Júnior JM; Tuon FF
    Can J Kidney Health Dis; 2020; 7():2054358120934215. PubMed ID: 32612844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study.
    Tecson KM; Erhardtsen E; Eriksen PM; Gaber AO; Germain M; Golestaneh L; Lavoria MLA; Moore LW; McCullough PA
    BMJ Open; 2017 Jul; 7(7):e016028. PubMed ID: 28698338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury.
    Neyra JA; Ortiz-Soriano V; Liu LJ; Smith TD; Li X; Xie D; Adams-Huet B; Moe OW; Toto RD; Chen J
    Am J Kidney Dis; 2023 Jan; 81(1):36-47. PubMed ID: 35868537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical acute kidney injury is associated with adverse outcomes in critically ill neonates and children.
    Fang F; Hu X; Dai X; Wang S; Bai Z; Chen J; Pan J; Li X; Wang J; Li Y
    Crit Care; 2018 Oct; 22(1):256. PubMed ID: 30305134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients.
    Shao M; Wang S; Parameswaran PK
    Int Urol Nephrol; 2017 Feb; 49(2):295-302. PubMed ID: 27817055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of C-C motif chemokine ligand 14 with other biomarkers for adverse kidney events after cardiac surgery.
    Massoth C; Küllmar M; Enders D; Kellum JA; Forni LG; Meersch M; Zarbock A;
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):199-207.e2. PubMed ID: 33832791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of transient and persistent acute kidney injury on short-term outcomes in very elderly patients.
    Li Q; Zhao M; Wang X
    Clin Interv Aging; 2017; 12():1013-1020. PubMed ID: 28721029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Cell Cycle Arrest Biomarkers for Predicting Acute Kidney Injury in Critically Ill COVID-19 Patients: A Multicenter, Observational Study.
    Weiss R; von Groote T; Ostermann M; Lumlertgul N; Weerapolchai K; Garcia MIM; Cano JMM; Del Corral BD; Broch-Porcar MJ; Perez Carrasco M; De la Vega Sanchez A; Sousa E; Catarino A; Roig AJB; Martinez de Irujo JB; de Rosa S; de la Peña MG; Tomasa T; Brivio M; De Molina FJG; Gerss J; Kellum JA; Wempe C; Leidereiter A; Meersch M; Zarbock A
    Crit Care Med; 2023 Aug; 51(8):992-1000. PubMed ID: 36975308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late acute kidney injury: temporal profile in the critically ill pediatric patient.
    Ruth A; Basu RK; Gillespie S; Morgan C; Zaritsky J; Selewski DT; Arikan AA
    Clin Kidney J; 2022 Feb; 15(2):311-319. PubMed ID: 35145645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.